<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVES: The objective of this study was to evaluate the prevalence, clinicopathologic features, and outcome of renal involvement in a large cohort of patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (PAPS) </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN, SETTING, PARTICIPANTS, &amp; MEASUREMENTS: We retrospectively examined medical records of 160 patients with a diagnosis of PAPS of two general hospitals of northern Italy between 1985 and 2008 </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: There were 140 women and 20 men </plain></SENT>
<SENT sid="3" pm="."><plain>Mean age was 35+/-12 yr </plain></SENT>
<SENT sid="4" pm="."><plain>PAPS was characterized by thrombotic events in 41.2%, fetal loss in 39.4%, and both in 19.4% </plain></SENT>
<SENT sid="5" pm="."><plain>Signs of renal abnormalities were present in 14 (8.7%) patients </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had <z:hpo ids='HP_0000093'>proteinuria</z:hpo>, in the nephrotic range in five; four patients had moderate <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0000083'>renal insufficiency</z:hpo>, and one had <z:e sem="disease" ids="C1261469" disease_type="Disease or Syndrome" abbrv="ESRD">end-stage kidney disease</z:e> (ESKD) </plain></SENT>
<SENT sid="7" pm="."><plain>Two patients presented with <z:hpo ids='HP_0001919'>acute renal failure</z:hpo> and one with <z:e sem="disease" ids="C0268732" disease_type="Disease or Syndrome" abbrv="">nephritic syndrome</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Ten patients underwent a renal biopsy, which showed a membranous <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo> in four, proliferative <z:hpo ids='HP_0000099'>glomerulonephritis</z:hpo> in two, <z:e sem="disease" ids="C0034155" disease_type="Disease or Syndrome" abbrv="">thrombotic microangiopathy</z:e> in two, and vascular lesions consistent with <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in two </plain></SENT>
<SENT sid="9" pm="."><plain>Patients with renal involvement were older (41.8 versus 34.3 years; P=0.0269), more frequently <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> positive (92.3 versus 48.9%; P=0.0068), and had hypocomplementemia (P&lt;0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Renal abnormalities are present in approximately 9% of patients with PAPS </plain></SENT>
<SENT sid="11" pm="."><plain>In addition to APS <z:hpo ids='HP_0000112'>nephropathy</z:hpo>, the prevailing picture is membranous <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Outcome and long-term follow-up usually are good </plain></SENT>
<SENT sid="13" pm="."><plain>Not <z:hpo ids='HP_0000001'>all</z:hpo> of the clinical manifestations of PAPS can be ascribed to thrombotic mechanisms </plain></SENT>
<SENT sid="14" pm="."><plain>The <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> of renal involvement confirms the presence of a continuum between <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> and PAPS </plain></SENT>
</text></document>